Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bruker Corporation (BRKR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
64.19+3.75 (+6.20%)
At close: 04:00PM EDT
64.19 0.00 (0.00%)
After hours: 04:42PM EDT
Advertisement

Bruker Corporation

40 Manning Road
Billerica, MA 01821
United States
978 663 3660
https://www.bruker.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees7,765

Key Executives

NameTitlePayExercisedYear Born
Dr. Frank H. Laukien Ph.D.Chairman, CEO & Pres2.44M7.68M1960
Mr. Gerald N. HermanExec. VP & CFO1.08MN/A1958
Dr. Mark R. Munch Ph.D.Corp. Exec. VP and Pres of Bruker Nano Group & Corp.1.54M1.27M1962
Mr. Juergen SregaPres of Bruker CALID Group & Bruker Daltonics Division960.8k13.26M1955
Dr. Falko Busse Ph.D.Pres of Bruker BioSpin Group738.54kN/A1968
Mr. Justin Joseph WardSr. Director of Investor Relations & Corp. Devel.N/AN/AN/A
Mr. J. Brent Alldredge J.D.Gen. CounselN/AN/A1975
Mr. Collin J. D'SilvaPres of Chemical Analysis DivisionN/AN/A1957
Stacey DesrochersTreasurer & Director of Investor RelationsN/AN/AN/A
Mr. Urban FaehPres of Bruker Optics Division & Managing Director of Bruker Optik GmbHN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Corporate Governance

Bruker Corporation’s ISS Governance QualityScore as of May 1, 2022 is 5. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 4; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement